Inflammatory bowel disease in adolescents.

Area of Science:

• Pediatric Gastroenterology
• Inflammatory Bowel Disease (IBD) Research
• Adolescent Health

Background:

• Approximately 20% of inflammatory bowel disease (IBD) cases are diagnosed in pediatric populations.
• Pediatric-onset IBD often presents with a more complicated and aggressive disease course compared to adult-onset IBD.
• General practitioners (GPs) play a critical role in the early diagnosis and ongoing management of pediatric IBD.

Purpose of the Study:

• To highlight the distinct characteristics of pediatric-onset IBD versus adult-onset IBD.
• To discuss updated treatment targets for pediatric IBD.
• To address practical management considerations for adolescents with IBD.

Main Methods:

• Review of current literature on pediatric IBD.
• Analysis of differences in disease presentation and progression between pediatric and adult IBD.
• Evaluation of treatment strategies and end-points in adolescent IBD management.

Main Results:

• Pediatric IBD is characterized by aggressive disease, growth failure, delayed puberty, and psychosocial challenges.
• Symptom control alone is inadequate for preventing long-term intestinal damage in pediatric IBD.
• Newer treatment goals emphasize achieving high rates of intestinal mucosal healing.

Conclusions:

• IBD in children and adolescents is more aggressive and presents unique challenges including growth and psychosocial development.
• Traditional symptom-focused treatment targets for IBD are insufficient to prevent ongoing bowel damage.
• Achieving intestinal mucosal healing represents a more effective treatment end-point for managing adolescent IBD.